Advisor Net Financial, Inc Grifols Sa Transaction History

Advisor Net Financial, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 04, 2022	SELL	$5.95 - $14.3 $2,796 - $6,721	-470 Reduced 93.25%	34 $0
Q1 2022 Apr 14, 2022	BUY	$10.37 - $12.73 $1,285 - $1,578	124 Added 32.63%	504 $6,000
Q4 2021 Jan 19, 2022	SELL	$10.21 - $15.27 $13,497 - $20,186	-1,322 Reduced 77.67%	380 $4,000
Q3 2021 Oct 15, 2021	BUY	$14.07 - $17.3 $23,947 - $29,444	1,702 New	1,702 $25,000
Q2 2021 Jul 06, 2021	SELL	$16.62 - $18.94 $4,155 - $4,735	-250 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$15.15 - $19.78 $3,787 - $4,945	250 New	250 $4,000
Q3 2020 Nov 06, 2020	SELL	$15.4 - $20.16 $10,872 - $14,232	-706 Closed	0 $0
Q2 2020 Aug 26, 2020	SELL	$18.24 - $21.45 $839 - $986	-46 Reduced 6.12%	706 $13,000
Q1 2020 May 14, 2020	SELL	$16.28 - $25.63 $455 - $717	-28 Reduced 3.59%	752 $15,000
Q4 2019 Feb 12, 2020	BUY	$19.57 - $23.52 $5,675 - $6,820	290 Added 59.18%	780 $18,000
Q1 2019 May 14, 2019	BUY	$18.01 - $20.11 $8,824 - $9,853	490 New	490 $10,000
Q4 2018 Feb 08, 2019	SELL	$17.44 - $21.53 $8,650 - $10,678	-496 Closed	0 $0
Q2 2018 Jul 27, 2018	BUY	$20.16 - $24.68 $9,999 - $12,241	496 New	496 $11,000
Q1 2018 May 08, 2018	BUY	$20.31 - $24.95 $0 - $0	0 New	0 $0

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.